Casamajo, A. R., Yu, Y., Schnepel, C., Morrill, C., Barker, R., Levy, C. W., Finnigan, J., Spelling, V., Westerlund, K., Petchey, M., Sheppard, R. J., Lewis, R. J., Falcioni, F., Hayes, M. A., & Turner, N. J. (2023). Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters. Journal of the American Chemical Society, 145(40), 22041-22046. https://doi.org/10.1021/jacs.3c07010